Macrogenics (MGNX) Operating Leases (2012 - 2026)

Macrogenics (MGNX) has reported Operating Leases for 13 consecutive years, with $31.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Leases fell 2.5% year-over-year to $31.3 million; the TTM figure through Mar 2026 stood at $31.3 million (down 2.5% YoY), while the FY2025 annual figure was $31.6 million, down 3.1% from the prior year.
• Operating Leases eased to $31.3 million in Q1 2026 per MGNX's latest filing, from $31.6 million in the prior quarter.
• Across five years, Operating Leases topped out at $32.6 million in Q4 2024 and bottomed at $17.0 million in Q3 2022.
• Historically, Operating Leases has averaged $28.6 million across 5 years, with a median of $30.2 million in 2023.
• Annual changes were most pronounced in 2022 — Operating Leases slipped 22.81% — and 2023, when it jumped 77.54%.
• Macrogenics' Operating Leases stood at $30.1 million in 2022, then rose by 0.3% to $30.2 million in 2023, then increased by 7.95% to $32.6 million in 2024, then decreased by 3.1% to $31.6 million in 2025, then dropped by 0.92% to $31.3 million in 2026.
• Business Quant data shows MGNX's Operating Leases at $31.3 million in Q1 2026, $31.6 million in Q4 2025, and $31.9 million in Q3 2025.